TN Health System Leverages Data Analytics to Advance Value-Based Care
Tennessee-based primary… read more
Tennessee-based primary… read more
December 1st is World AIDS Day, when we collectively remember those who died due to AIDS-related illnesses and renew our commitment to work together to […]
Hospital operators are continuing to report rising losses in a tricky operating environment, with staffing shortages and high labor costs pressuring finances.
Thanks to the convergence of cloud technologies, AI, and refined lung data, we are in a new era for those with chronic lung disease. In […]
Anti-lockdown protests erupted across China following a deadly apartment fire in Xinjiang last week. The country’s zero-COVID policy may have been to blame, as first […]
FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans, using the Accelerated Approval pathway
Children and adults have been treated using the Lyme disease antibody candidate VLA15
Novel tuberculosis vaccine tested in a large phase 3 trial against severe respiratory infection disease
Linkam Scientific Instruments’ NEXUS software enables holistic environmental controls in experiments.
As part of the Digital Innovation Hub at La Trobe University, Cisco’s Innovation Central Melbourne set out to define digital literacy for healthcare. With this […]
What happens when you add massive amounts of carbohydrates in the form of whole grains to the daily diet of people with type 2 diabetes? […]
A potential flurry of regulatory activity could be on the horizon yet this year — and several key drug approvals are at stake.
Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic.
A potential flurry of regulatory activity could be on the horizon yet this year — and several key drug approvals are at stake.
Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic.
Results from a Phase II/III study, published in The Lancet, showed a single, oral dose of acoziborole was up to 95 percent successful in treating […]
Annals of Pharmacotherapy, Volume 57, Issue 8, Page 997-998, August 2023.
Annals of Pharmacotherapy, Ahead of Print.
Annals of Pharmacotherapy, Ahead of Print.
Annals of Pharmacotherapy, Ahead of Print.
Annals of Pharmacotherapy, Ahead of Print.
Annals of Pharmacotherapy, Ahead of Print.
Annals of Pharmacotherapy, Ahead of Print.
Annals of Pharmacotherapy, Volume 57, Issue 8, Page 940-947, August 2023. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and […]
Annals of Pharmacotherapy, Ahead of Print. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and workload for personnel compared to […]
Annals of Pharmacotherapy, Ahead of Print. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and workload for personnel compared to […]
Annals of Pharmacotherapy, Ahead of Print. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and workload for personnel compared to […]
Annals of Pharmacotherapy, Ahead of Print. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and workload for personnel compared to […]
Annals of Pharmacotherapy, Ahead of Print. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and workload for personnel compared to […]
Annals of Pharmacotherapy, Ahead of Print. Background:Vancomycin area-under-the-curve (AUC) monitoring is associated with reduced nephrotoxicity but may increase cost and workload for personnel compared to […]
In a webinar, flipMD and physicians discussed how the organization connects pioneering healthcare companies with expert physicians to maximize patient impact.
Shots: The collaboration will combine AbCellera’s Ab discovery engine with Rallybio’s clinical and commercial expertise in rare diseases to identify optimal clinical candidates and deliver […]
Staff pay awards have outstripped increases in core GP practice funding between 2019/20 and 2021/22, piling pressure on primary care finances well before the current […]
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
Ongoing | Infectious Disease Accelerated Approvals (excluding vaccines)
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
To allow for earlier approval of drugs that treat serious conditions and fill an unmet medical need based on a surrogate endpoint
Myeloma Patients Europe (MPE) has identified significant inequalities among patients’ access to myeloma clinical trials in Central and Eastern Europe (CEE) in a first-of-its-kind advocacy report. […]
Shots: BioStrand to receive an up front of $500,000 & will be eligible to receive future success-based development & clinical milestones along with royalties, following […]
Shots: BioStrand to receive an up front of $500,000 & will be eligible to receive future success-based development & clinical milestones along with royalties, following […]
05/12/2022 Exploring OiRA tools dedicated to the hotel sector in Greece Image Owners, management personnel and safety technicians from hotels in the Crete region benefit […]
Rebyota, the first faecal microbiota product to prevent recurrence of Clostridioides difficile infection (CDI) in people 18 years and older after being given antibiotics for […]
Shots: The combined company will have pro forma enterprise value of ~$334M, gross cash proceeds of ~$316M, $276M in Iris’ trust account & concurrent, $15M […]
Consumers can order groceries or rent a car with just a few clicks, so paying for medical care often feels frustratingly complex in comparison. Bewildering […]
Doctors say they need to be paid for their time spent sending patient messages through portals such as Epic Systems’ MyChart. But payers and patient […]
In another win for Bayer, the Scottish Medicines Consortium (SMC) has accepted the company’s chronic kidney disease (CKD) drug, Kerendia (finerenone), for the treatment of […]
ATLANTA — When Louana Joseph’s son had a seizure because of an upper respiratory infection in July, she abandoned the apartment her family had called […]
MARSHALLTOWN, Iowa — Andrea Storjohann is glad to see that she’s becoming less of a rarity in rural America. The nurse practitioner prescribes medication to […]
A Montana law requiring public schools to notify parents of lessons that mention human sexuality — and allowing parents to pull their children from those […]
In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock chats with Gita Barry, EVP and GM of Immersive Healthcare at Penumbra, […]
Shots: The US FDA has accepted the sBLA for Priority Review of Evkeeza as an adjunct to other lipid-lowering therapies in children aged 5-11yrs. with […]
Shots: The US FDA has accepted the sBLA for Priority Review of Evkeeza as an adjunct to other lipid-lowering therapies in children aged 5-11yrs. with […]
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found […]
Shots: Ryvu will receive $20.89M up front in exchange for rights to Ryvu’s STING agonist portfolio, $20.89M in equity investment & is also eligible to […]
Shots: The P-III (TRAILBLAZER-ALZ 4) study evaluates donanemab vs aducanumab in 148 patients aged 50-85yrs. with early symptomatic AD treated with amyloid-targeting therapies The trial […]
Ipca Laboratories Ltd- Walk-In Interviews for Formulation Development/ Analytical Development On 10th Dec’ 2022 Job Description Walk-In Interviews for Formulation Development/ Analytical Development On 10th […]
[![saxagliptin structure](https://www.DrugPatentWatch.com/img/drug-structure/saxagliptin.png)](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents […]
[![eltrombopag structure](https://www.DrugPatentWatch.com/img/drug-structure/eltrombopag.png)](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting […]
This chart shows the drugs with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) […]
Selmar Lab Pvt. Ltd-Walk-In Interview for Production/ QC/ QA/ Safety Dept. On 2nd & 3rd Dec’ 2022 Job Description Selmar Lab Pvt. Ltd is located […]
APL Health Care (Aurobindo )-Walk-In Interviews for Quality Assurance/ Quality Control On 2nd Dec’ 2022 Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing […]
Aragen Life Sciences (GVK Bio) – Walk-In Interviews On 3rd & 4th Dec’ 2022 @ Noida & Ahmedabad Job Description Greetings from Aragen Life Sciences […]
The post New drug to treat prostate cancer may be out of reach for most Canadians appeared first on Healthy Debate.
Patient privacy is evolving rapidly in the post-Dobbs era, according to healthcare and life science lawyers in a webinar hosted by the American Bar Association […]
Applicability of the HCS to Lithium Ion Batteries – [1910.1200; 1910.1200(b)(1); 1910.1200(b)(5)(v); 1910.1200(b)(6)(v); 1910.1200(b)(6)(ix); 1910.1200(c); 1910.1200(d)(1)]
December 15 is the deadline to apply for, renew, or change your Marketplace health insurance for 2023 coverage that starts January 1. Don’t delay – […]
Copyright © 2024 | WordPress Theme by MH Themes